Coherus Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.76

+0.07 (+4.14%)

As of Apr 1, 2:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +1,956.8% upside

Low Target $24.75

Average Target $36.20

High Target $54.95

Current Price $1.76

Current
$1.76

Target
$36.20

$24.75 $36.20 avg $54.95

Scenario Analysis

Bear Case

$24.75

1,306.3%

Low target

Base Case

$36.20

+1,956.8%

Avg target

Bull Case

$54.95

+3,022.2%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$44.36

-96.0% from high

52-Week Low

$19.01

+-90.7% from low

Target vs 52W High

$36.20

-18.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%